Positron emission tomography (PET) is a nuclear imaging technique used to diagnose conditions such as cancer. An innovative advance from scientists at...
Vous n'êtes pas connecté
THURSDAY, Jan. 9, 2025 -- Among patients with high-risk prostate cancer and no evidence of metastatic disease on conventional imaging, prostate-specific membrane antigen-positron emission tomography (PSMA-PET) results were positive in 84 percent of...
Positron emission tomography (PET) is a nuclear imaging technique used to diagnose conditions such as cancer. An innovative advance from scientists at...
A large-scale study has found huge variation between GP practices on whether they are likely to pick up prostate cancer using a blood test. The...
bmedlinkPositron emission tomography/medlink/b (PET), a nuclear imaging technique commonly used to diagnose conditions like medlinkcancer/medlink,...
TOPLINE: Healthier lifestyles were associated with improved overall survival but not prostate cancer–specific survival in a multiethnic cohort of...
Positive topline results from the DESTINY─Gastric04 phase 3 trial showed Enhertu (trastuzumab deruxtecan) demonstrated a statistically significant...
In metastatic cancer surveillance, monitoring the actual concentrations of circulating tumour DNA (ctDNA) may be critical. Researchers showed that...
Patients with castration-resistant metastatic prostate cancer with or without HRR gene alterations treated with a combination of talazoparib and...
A new study of more than 2,900 patients provides evidence that it's likely best to use as little corticosteroid medicine as possible when treating...
MONDAY, March 3, 2025 -- For patients with type 2 diabetes, chronic kidney disease, and additional cardiovascular risk factors, the dual...
A new study from the UK found that a mobile prostate cancer screening clinic called the “Man Van” helped address some barriers to screening by...